-
-
-
-
-
-
-
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK
-
-
-
-
-
-
-
ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP
-
-
-
-
-
-
-
ViiV Healthcare to announce data from largest head-to-head randomised clinical trial for 2-drug regimen Dovato against 3-drug regimen Biktarvy at AIDS 2024
-
-
-
-
-
-
-
GSK (GSK) Acquires Aiolos Bio for Up to $1.4B
-
-
-
-
-
-
-
BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
-
-
-
-
-
-
-
ViiV Healthcare Announces New Data at AIDS 2022 From Unblinded Phase of HPTN 084 Study in Women in Sub-Saharan Africa Showing Continued Superior Efficacy of Injectable Cabotegravir Long-Acting for PrE
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/13: (ATRS) (SRRA) (STAB) Higher; (NSTG) (LQDA) (BBBY) Lower (more...)
-
1,158,058 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

